CORE LABS INC (CLB)
(Delayed Data from NYSE)
$16.97 USD
-0.21 (-1.22%)
Updated Apr 22, 2024 04:00 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
Price, Consensus and EPS Surprise
CLB 16.97 -0.21(-1.22%)
Will CLB be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CLB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CLB
Kinder Morgan (KMI) Beats on Q1 Earnings, Hikes Dividend
Sunoco (SUN) Proceeds With Strategic Portfolio Optimization
CLB: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Core Laboratories (CLB) a New Strong Buy Stock
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Other News for CLB
Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO
Christina Lake Cannabis Updates on MCTO Status
Core Laboratories price target lowered by $1 at BofA, here's why
Core Laboratories Reaches Analyst Target Price
Top buy-rated stocks and sell-rated stocks within Energy - Citi